Cornell is partnering with New York state and Northwell Health System to develop and train the nation’s first state public health corps, which will support COVID-19 vaccination and improve long-term public health outcomes.
Douglas Lankler, J.D. ’90, executive vice president and general counsel at Pfizer, has played a leading role in establishing Pfizer’s agreement with the U.S. government for 100 million doses of a COVID-19 vaccine.
A comparative analysis of COVID-19 policies across 18 countries, led by researchers from Cornell and Harvard University, shows that varied public health and economic outcomes are linked to underlying characteristics of each society.
Mobile contact-tracing technology has emerged as one way to contain COVID-19, but contact tracing apps, which require a critical mass of adopters to be effective, face serious obstacles in the U.S., Cornell researchers have found.
Grants awarded recently by the Cornell Center for Social Sciences seeded research projects on topics ranging from COVID-19 and policing to clean energy and product design, led by scholars from across the university.